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Triglyceride to high-density lipoprotein cholesterol and 
low-density lipoprotein cholestrol to high-density 
lipoprotein cholesterol ratios are predictors of 
cardiovascular risk in Iranian adults: Evidence from a 
population-based cross-sectional study 
 
Abstract 
Background: The superiority of TG/HDL-C and LDL-C/HDL-C ratios in predicting  CVD 
risk is a matter of debates. Thus, the objective of this study was to compare TG/HDL-C 
and LDL-C to HDL-C ratios in predicting the risk of CVD events. 
Methods: In a population-based cross-sectional study, 567 representative participants aged 
40 years or older were entered in the study in Babol, North of Iran. The demographic data, 
anthropometric measures, and the cardio metabolic risk factors were measured. The 
individual risk of CVD events was assessed by ACC/AHA risk model. ROC analysis was 
applied to estimate the diagnostic accuracy and the optimal cut-off points of TG/HDL-C 
and LDL-C/HDL-C ratios. 
Results: The AUC of TG/HDL-C and LDL-C/HDL-C ratios were rather similar and both 
parameters significantly predicted CVD risk in men comparably, and TG/HDL-C at 
optimal cutoff point of 3.6 produced 75% sensitivity and 39% specificity. However,in 
women TG/HDL-C with AUC of 0.65( p=0.091) at optimal cutoff value of 3.4  produced a 
sensitivity of 82% and specificity of 51%. The LDL-C/HDL-C ratio had no discriminative 
ability in predicting CVD risk in women.  
The adjusted OR of TG/HDL-C at 2nd quartile was significant (OR=3.22, 95% CI:1.25-
8.29) and a greater association was found with 3rd and 4rth quartiles  
Conclusion: Both TG/HDL–C and LDL-C/HDL-C ratios comparably predict CVD risk in 
men, whereas in women only TG/ HDL-C is a significant predictor but not LDL-C/HDL-C. 
Keywords: Triglyceride, HDL- cholesterol, Triglyceride/HDL-cholesterol ratio, LDL-
cholesterol, LDL-cholesterol/HDL-cholesterol ratio, Cardiovascular risk 
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Cardiovascular diseases as a major public health problem worldwide are the main 
causes of death both in the developing and industrial countries (1). Metabolic syndrome 
(MetS) and diabetes alone and/or in combination are also predictors of cardiovascular 
mortality (2). It is well-established that obesity, insulin resistance and hyperlipidaemia are 
the central components of MetS (2, 3). There is evidence that the pattern of cardiovascular 
risk factors and their contribution in mortality have changed dramatically in Iranian 
population in recent decades (4, 5). According to the epidemiological transition model, the 
Iranian population had experienced cardiovascular events rapidly because of changing 
toward western lifestyles.  
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A high prevalence of obesity, dyslipidemia, impaired 
glucose tolerance, type 2 diabetes, and metabolic syndrome 
were responsible for the development of higher than 
expected mortalities in Iranian populations (6-10). The high 
level of triglyceride (TG) and the low level of high-density 
lipoprotein cholesterol (HDL-C) are associated with insulin 
resistance, type 2 diabetes and thus metabolic syndrome (11-
13).
 
Both conditions have been considered as components of 
metabolic syndrome by the World Health Organization (WHO), 
International Diabetes Federation (IDF), Adult Treatment 
Panel (ATP III) and National Heart Lung and Blood 
Institute/American Heart Association (NHLBI/AHA) (13-16).  
Additionally, a single dimensional measure has been 
defined by TG/ HDL-C ratio, as an index of heart disease 
mortality and incidence of type 2 diabetes mellitus in men 
(17). As a TG/HDL ratio of > 3.5 is associated with impaired 
glucose tolerance, type 2 diabetes, atherogenic dyslipidaemia 
and metabolic syndrome (17), and particularly in obese and 
diabetic patients as well as in obese children. This measure is 
associated with an increased risk of cardiovascular disease 
and its consequent mortality (19-21). Furthermore, low-
density lipoprotein cholesterol (LDL-C) plays a basic 
metabolic role in the pathogens of cardiovascular disease 
(CVD) (22, 23), but its independent association with MetS 
has not been established yet clearly, so it was not considered 
as a component of MetS (24).
 
On the other hand, small dense 
low-density lipoprotein (sd-LDL) particles are also linked 
with CVD risk (25, 26)
 
but their application as a routine 
biochemical test is not clinically applicable. Nevertheless, 
the ratio of low density cholesterol to high-density 
lipoprotein cholesterol (LDL-C/HDL-C ratio) provides a 
simple measure to identify dyslipidaemic patients.  
The present evidence suggested that the LDL-C /HDL 
ratio was an independent predictor of coronary stenosis and 
coronary artery plaques (27). However, the optimal cutoff 
values of both LDL-C/HDL-C and TG/HDL-C as one-
dimensional ratio indexes are dependent on ethnicity and 
gender (28). Therefore, the superiority of these two ratio 
measures and their optimal cutoff values in predicting 
cardiovascular risk in the general population remain to be 
determined. Since the relative ability of TG- to- HDL-C ratio 
and LDL-C –to- HDL-C ratios in recognizing the 
cardiovascular risk in general population have not been 
established yet, data in this regard in Iranian adult population 
are also scarce. We, therefore, performed the present study to 
examine and compare the ability of these measures in 
predicting 10-year risk of CVD by using the American 
College of Cardiology/American Heart Association 
(ACC/AHA) risk model (29). 
 
 
Methods  
The data of this study extracted from a population-based 
cross-sectional of Babol Glucose and Lipid study was 
originally designed to examine the prevalence of 
cardiometabolic risk factors in a population living in a 
geographic region located in the south of the Caspian Sea, 
North of Iran in 2012. The original data included one 
thousand representative samples of the adult population aged 
20 to 70 years. The two-stage cluster sampling method was 
used in the selection of the study subjects in the urban 
community. All participants had given a written consent 
prior to participation in the study and the study protocol was 
approved by the Ethics Committee of Babol University of 
Medical Sciences. For the current analysis, 567 subjects 
without a prior history of CVD events aged 40 years or older 
entered the study.  
Data collection: Details of sample selection and data 
collection were described elsewhere (8). In brief, 25 random 
clusters were selected at community under coverage of 
health care systems and within each cluster, about 40 
subjects were selected. All participants were interviewed and 
clinically examined at home visit in a family health survey. 
The data regarding demographic characteristics, anthropometric 
measures and blood pressure (systolic and diastolic blood 
pressure (SBP), diastolic blood pressure (DBP) were 
provided at home visit and from them, the mean arterial 
pressure(MAP) was calculated as MAP=DBP+0.33 (SBP-
DBP).Then all participants were invited to the central lab of 
the Ayatollah Rouhani Hospital with 10-12 hours overnight 
fasting for assessment of total cholesterol (TC), TG, HDL-C 
and, LDL-C and fasting blood sugar (FBS) with the 
enzymatic method. The ratios of TG to HDL-C and LDL-C 
to HDL-C were calculated for all participants. The body 
mass index was calculated as weight in kg dividing by height 
in m
2
 and the waist circumference >102 cm for men and >88 
cm for women were considered as abdominally obese. 
Statistical Analysis: In statistical analysis, we used SPSS 
software Version 18 and Stata software Version 13.0. First, 
ACC/AHA 10-year risk model of CVD events was applied 
to assess the individual risk of CVD based on 
cardiometabolic risk profiles of the participants (24). The 
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sex-ethnic baseline risk and the related coefficients of the 
Cox regression model suggested by ACC/AHA were used 
for individual risk assessment. We used the Caucasian ethnic 
baseline risk that corresponds to the ethnicity of the study 
population. Then, the quantitative risk was dichotomized 
into two categories as low risk (<10%) and high risk (≥10%). 
In bivariate analysis, the low and high-risk groups were 
compared with regard to TG/HDL-C, LDL-C /HDL-C ratios, 
and other cardiometabolic risk factors using independent 
sample t-test for normally distributed data and Wilcoxon 
rank test for variables with non-normal distribution 
according to gender. ROC curve analysis was applied to 
estimate the accuracy of TG/HDL-C and LDL-C/HDL-C 
ratios in differentiating high risk versus low-risk individuals 
with the calculation of the area under the curve (AUC) 
obtained from the same study population. The covariance 
structure of Delong method with Stata software was used to 
characterize and test the superiority of either of these two 
ratio biomarkers. The optimal cutoff value of each biomarker 
was estimated using Youdens' index that maximizes the total 
correct classification which was determined by 
sensitivity+specificity-1. This index maximizes sensitivity 
and specificity. Then the sensitivity and specificity of each 
measure were determined at the optimal cutoff point. The 
diagnostic accuracy of each ratio index as defined by the 
area under ROC curve (AUC) was determined with 95% 
confidence interval. The ability of  higher tops quartiles 
versus  1st quartile  of  TG/HDL-C and LDL-C /HDL-C 
ratios  in association with  high risk versus low-risk 
individuals was  determined with calculation of  odds ratio 
(OR) and the corresponding 95% confidence interval using 
logistic regression model after adjustment for age, sex and 
educational level, BMI, abdominal obesity, mean arterial 
pressure, and FBS. In all analysis, we used two-sided test 
and the p-values less than 0.05 were considered as 
significant level. 
 
 
Results 
The mean age of the male and female participants were 
53.4±8.9 and 51.3±8.2 years respectively. The mean value of 
TG/HDL-C ratio was significantly greater in men than 
women (5.79±4.22 versus 3.67±1.32, P=0.04), whereas, the 
mean value for LDL-C /HDL-C ratio did not differ between 
the two sexes (3.54±1.31 versus 3.67±1.32, P=0.25). 
Overall, 28% of the participants were in high (≥10%) CVD 
risk group (42.5% men versus 15.1% women, P=0.001). In 
table 1, men and women in high and low CVD risk groups 
were compared according to cardiometabolic risk factors as 
well as TG/HDL-C and LDL-C/HDL-C ratios. In men, all 
metabolic risk factors, in particular, TG/ HDL-C and LDL-
C/HDL-C ratios were significantly higher in high risk 
compared to low-risk group, but in women, the pattern was 
rather different and a significant difference was observed 
only between  TG, FBS, SBP, DBP, and TG/HDL ratio, 
whereas, the difference in LDL-C, HDL-C, BMI, WC, and 
LDL-C/HDL-C ratio did not reach to a statistically 
significant level. 
Table 2 summarizes the diagnostic accuracy of TG/HDL-
C and LDL-C/HDL-C ratio and their optimal cutoff values in 
predicting CVD events according to sex. In men, the 
TG/HDL-C and LDL-C/HDL-C ratios yielded similar 
accuracy in differentiating low and high-risk groups at a 
significant level, and the TG/HDL-C ratio at cutoff level of 
3.6 yielded a sensitivity of 75% and specificity of 39%. 
However, the predictive accuracy (AUC) of TG/HDL-C ratio 
in women was greater than men (P=0.001), and at cutoff 
value of 3.4 yielded a sensitivity and specificity of 82% and 
41%, respectively. While LDL-C/HDL-C ratio in women 
showed no discriminative ability in differentiating high 
versus low CVD risk group (AUC=0.53, P=0.46). Figure 1 
shows the ROC curves for the two ratio biomarkers in panel 
(a) for men and panel (b) for women. 
In table 3, the association of higher quartile versus 1st 
quartile for both biomarkers with cardiovascular risk was 
shown by unadjusted OR after controlling for age, sex, 
educational level, BMI, abdominal obesity, mean arterial 
pressure, and FBS. The strength of association increased 
further at higher quartiles after adjustment. The ability of 
TG/HDL-C in the differentiation of high from low-risk CVD 
risk group at 4th quartile was 4.51 (95% CI: 1.80–11.25, P= 
0.001) times greater than the 1st quartile. The association of 
LDL-C/HDL-C ratio reached to a statistically significant at 
3rd and 4th quartiles after adjustment, but not at 2nd quartile 
level. Further stratified analysis by gender showed no 
significant association between  quartiles of LDL-C/HDL- 
ratio and CVD risk in women but the  magnitude of adjusted 
OR for  TG/HDL-C was inefficiently large in women since, 
the data of outcome of interest (>10% CVD risk) was sparse 
in the 1st quartile of TG/HDL-C in women. 
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Table 1. The mean (SD) of cardiometabolic risk factors in low and high cardiovascular risk according to sex 
 
Cardiometabolic risk factors CVD risk P-value 
 <10% 
Mean (SD) 
>=10% 
Mean (SD) 
 
Men 
Cholesterol (mg/dl) 
 
48.1 (5.6) 
 
60.5 (7.5) 
 
0.001 
TG (mg/dl) 190.6 (38.9) 210.4 (78.5) 0.007 
LDL-C (mg/dl) 180.8 (115.3) 215.8 (134.4) 0.02 
HDL-C (mg/dl) 118.7 (36.3) 127.4 (43.9) 0.08 
FBS  (mg/dl) 105.0 (32.5) 128.5 (48.8) 0.003 
BMI (kg/m
2
) 26.3  (3.6) 27.6 (6.8) 0.03 
WC (cm) 93.0 (13.3) 96.9 (15.9) 0.04 
DBP  (mm/Hg) 81.9 (12.9) 87.3 (13.4) 0.001 
SBP (mm/Hg) 126.1 (13.9) 135.5 (17.3) 0.001 
TG/HDL-C 5.14 (3.74) 6.69 (4.68) 0.003 
LDL-C/HDL-C 3.33 (1.24) 3.81 (1.35) 0.003 
Women    
Cholesterol(mg/dl) 211.6 (42.1) 222.1 (51.6) 0.13 
TG(mg/dl) 171.4 (101.2) 241.3 (223.4) 0.001 
LDL-C(mg/dl) 137.6 (40.9) 137.7 (47.0) 0.98 
HDL-C(mg/dl) 40.5  (15.7) 36.7 (8.6) 0.12 
FBS(mg/dl) 11.6 (40.7) 168.7 (88.3) 0.001 
BMI(kg/m
2
) 29.9 (5.7) 30.9 (5.7) 0.25 
WC(cm) 95.5 (15.4) 99.1 (15.3) 0.16 
DBP(mm/Hg) 84.2 (15.6) 91.7 (17.5) 0.004 
SBP(mm/Hg) 127.6 (18.3) 149.4 (18.3) 0.001 
TG/HDL-C 4.67 (3.46) 7.13 (7.87) 0.001 
LDL-C/HDL-C 3.63 (1.29) 3.88 (1.49) 0.25 
            CVD = Cardiovascular disease; TG=Triglycerides; LDL= Low density lipoprotein; HDL= High density lipoprotein cholesterol;  FBS= Fasting blood sugar 
           BMI = Body mass index; WC =Waist circumference; DBP= Diastolic blood pressure; SBP= Systolic blood pressure 
Table 2. The diagnostic accuracy of TG to HDL-C ratio and LDL-C to HDL-C ratio in predicting cardiovascular risk and 
their optimal cut-off values 
 
Predictors AUC (95% CI) P-value Optimal 
cut-off 
Sensitivity Specificity 
Men 
TG/HDL-C 
 
0.61 (0.54, 0.68) 
 
0.002 
 
3.6 
 
0.75 
 
0.39 
LDL-C/HDL-C 0.60 (0.53, 0.67) 0.004 3.2 0.68 0.42 
Women 
TG/HDL-C 
 
0.65 (0.57, 0.73) 
 
0.001 
 
3.4 
 
0.82 
 
0.41 
LDL-C/HDL-C 0.53 (0.44, 0.63) 0.46 3.1 0.69 0.47 
All   
TG/HDL-C 
 
0.63 (0.58, 0.68) 
 
0.001 
 
2.7 
 
0.89 
 
0.24 
LDL-C/HDL-C 0.56 (0.51, 0.61) 0.027 2.7 0.85 0.21 
       AUC= Area under the roc curve; TG=Triglycerides; LDL= Low density lipoprotein; HDL= High density lipoprotein cholesterol   
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Figure 1. ROC curve of TG/HDL-C and LDL-C/HDL-C ratios in predicting CVD risk, panel (a): Male, panel (b): Female 
   TG=Triglycerides; LDL-= Low density lipoprotein; HDL= High density lipoprotein cholesterol; CVD = cardiovascular disease  
 
Table 3. The unadjusted and adjusted odds ratio (OR) of TG/HDL-C and LDL-C/HDL-C ratios and the 95% confidence 
interval (CI) in predicting cardiovascular risk 
Cardio metabolic risk factors Unadjusted OR 
(95% CI) 
P-value Adjusted
╞
OR 
(95% CI) 
P-value 
TG/HDL-C  0.001  0.012 
1
st
 quartile 1 ( ref) - 1 (ref) - 
2
nd
 quartile 2.51 (1.37, 4.60) 0.003 3.22 (1.25, 8.39) 0.02 
3
rd
 quartile 2.59 (1.41, 4.74) 0.002 3.85 (1.48, 9.99) 0.005 
4rth quartile 4.28 (2.38, 7.72) 0.001 4.51 (1.80, 11.25) 0.001 
LDL-C/HDL-C  0.22  0.001 
1
st
 quartile 1 (ref) - 1 (ref) - 
2
nd
 quartile 1.10 (0.64, 1.90) 0.78 1.06 (0.44, 2.50) 0.89 
3
rd
 quartile 1.47 (0.87, 2.48) 0.15 3.18 (1.38, 7.33) 0.007 
4rth quartile 1.62 (0.95, 2.73) 0.07 4.46 (1.91, 10.42 0.001 
                                    The odds ratio was adjusted by age, sex, educational level, body mass index (BMI), abdominal obesity, 
                                       mean arterial pressure (MAP) and fasting blood sugar (FBS). 
 
Discussion 
These findings indicated that 28% of the study 
population especially male subjects were at high risk for 
developing cardiovascular events, and cardiometabolic risk 
factors were more prevalent in high CVD risk group 
compared to low-risk group. In this setting the TG/ HDL-C 
ratio at cut-off level of 3.6 recognized high CVD risk group 
at sensitivity of 75% and specificity of 39% and LDL-
C/HDL-C ratio with cut-off point of 3.5 yielded  a sensitivity 
and specificity of 82% and 41%, respectively for 
differentiation of high and low CVD risk groups. The  
 
association of TG/HDL-C with CVD risk at higher quartiles  
was stronger. Both indexes yielded similar accuracy in men, 
but in women, LDH-C/HDL-C ratio was not associated with 
CVD risk. 
These findings are in agreement with the results of earlier 
studies which have addressed the association between 
TG/HDL-C ratio and risk factors of CVD events such as 
diabetes, metabolic syndrome, dyslipidemia, hypertension, 
and insulin resistance (19, 25, 30-34). The association 
between TG/HDL-C and cardiovascular events has also been 
shown in two longitudinal studies of Iranian populations (28, 
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31). In another longitudinal study of 39447 men, the 
predictive ability of TG/HDL-C ratio was comparable or 
better than the metabolic syndrome. In this study, TG/HDL-
C ratio > 3.5 predicted future development of cardiovascular 
diseases and coronary heart deaths, and the annual incidence 
of diabetes was 2 times higher as compared with TG/HDL-C 
ratio < 3.5 (17). In the Korean National Health and Nutrition 
Examination Survey in 2013 and 2014, the TG/HDL-C ratio 
at cutoff point ≥ 3.52 was significantly associated with 
metabolic syndrome (33).
 
 The TG/HDL-C ratio was also 
associated with hypertension, hypercholesterolemia, and 
hypertriglyceridemia in both sexes (30). In overweight and 
obese, hypertensive individuals, higher TG/HDL-C ratio is a 
predictor of cardiovascular diseases and a higher incidence 
of fatal and nonfatal cardiovascular events (19, 35). In 
conditions with an inflammatory process such as patients on 
haemodialysis and rheumatoid arthritis (36, 37), the elevated 
TG/HDL-C ratio is associated with cardiovascular deaths 
and overall-cause death (38). Even in healthy adults and 
children, high TG/HDL-C ratio is a marker for future 
development of cardiovascular diseases (21, 39).  
The results regarding the ability of high LDL-C/HDL-C 
ratio in recognizing high-risk individuals for CVD events in 
men, as found in this study, are also in line with other studies 
(27, 40, 42). One large study of subjects aged > 35 years old 
found that LDH-C/HDL-C ratio was a marker of 
hypertension and hypercholesterolemia in both men and 
women in a Canadian population (40). In another study of 
101 Japanese, the LDL-C -to-HDL-C ratio was an 
independent predictor of coronary artery stenosis and 
vulnerable coronary artery plaque in diabetic patients (27). In 
contrast, in a prospective study of 356 patients with acute 
intracranial hemorrhage, patients at the lowest quartiles of 
LDL-C /HDL-C ratio had the highest cumulative incidence 
rates of all-cause mortality with 3.55- fold increase in the 
risk of all-cause mortality as compared with highest quartiles 
(41). Based on available data, elevated serum triglycerides is 
commonly associated with reduced HDL-C and increased 
number of small dense low-density lipoprotein (17). 
Triglycerides themselves are strong risk factors for 
cardiovascular events but stratifying by HDL-C levels 
provides a more accurate measure in detecting high-risk 
individuals (43). Nevertheless, an analysis of data from the 
cohort of the Quebec Cardiovascular Study during a 13-year 
follow-up period, revealed a significant association between 
the Log TG/HDL ratio and features of LDL size phenotype 
which was comparable to TG alone (44). Although, 
increased levels of some lipids are associated with higher 
risk of coronary heart disease, but, cardiac risk of 
cardiovascular disease for small dense LDL particles has 
been established. However, routine assessment of these 
lipoproteins is not practical instead, several indexes 
including TG/LDL-C ratio, the ratio of total cholesterol to 
HDL-C and, to a lesser extent, the ratio of LDL-C to HDL 
have been used to assess atherogenic lipoproteins status for 
predicting coronary artery disease. Among several indexes, 
ratios that have atherogenic particles in the numerator and 
HDL-C or its constituents in the denominator yield stronger 
ability in predicting cardiovascular disease. As a result, 
TG/HDL-C ratio proved to be a highly significant 
independent predictor of myocardial infarction, even 
stronger than TC/HDL-C and LDL-C /HDL-C, because, 
triglycerides have high plasma concentration of lipoprotein 
for generation of small dense LDL (31, 43). In addition, the 
TG/HDL-C ratio is a marker of insulin resistance which acts 
differently regarding ethnicity and sex and correlates with 
other atherogenic lipids such as TG-rich lipoproteins, 
remnant, and small dense LDL particles. Moreover, it can be 
used as a measure of glycemic control especially in obese 
patients with type 2 diabetes (20). As shown in this study, 
the predictive ability of TG/HDL-C has been addressed in 
other Iranian populations (28, 31). One large prospective 
study of Iranian men aged > 40 years old, free of 
cardiovascular diseases, over 6.5 years of follow-up period 
cardiovascular events occurred in 15.5% of subjects in the 
top quartile and 4.9% in the first quartile. The prevalence of 
metabolic syndrome in subjects with TG/HDL ratio > 6.9 
reached 63.6% versus 3% in those with TG/HDL ratio < 2.8 
(31). Based on the findings of the present study, 75% of 
high-risk CVD events in men and 0.82% of women can be 
predicted by TG/HDL-C ratio > 3.6, and >3.4, respectively. 
However, the specificity of both TG/HDL-C and LDL/HDL 
ratios was low, so about 60% of subjects of the low-risk 
group for CVD may yield false positive results. Nonetheless, 
the identification of high-risk individuals by using an 
inexpensive measure is of particular importance. Especially, 
the ability of these measures in recognizing apparently 
healthy young adult and children who are at risk of future 
development of cardiovascular events provides an 
opportunity for preventive measures. 
This study has limitations regarding study design which 
is cross-sectional and the association does not indicate 
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causality. In addition, in calculating risk in ACC/AHA 
model, the baseline risk was taken into account from non-
Hispanic Caucasian. This ethnic group might have rather a 
similar baseline risk to Iranian population according to 
similar ethnicity.    
 Although the confounding effects of several associated 
factors of CVD, such as age, sex, BMI, abdominal obesity, 
diabetes, hypertension and thus components of metabolic 
syndrome (except for lipid profiles) have been controlled by 
logistic regression model, the effects of unknown covariates 
could not be ignored. However, the results are probably less 
confounded since the distributions of unknown covariates 
are expected to be similar across comparison groups. 
However, the population-based subject selection, performing 
a standard sampling procedure with adequate sample size 
and appropriate method of data collection and analysis 
enhance the validity and reliability of the study. 
In conclusion, this study indicates that TG /HDL-C and 
LDL-C /HDL-C ratios are easy and accessible measures in 
recognizing individuals who are at higher risk of CVD. 
However, this issue requires a longitudinal study of healthy 
individuals, and serial measurement of TG, LDL-C, HDL-C 
and other associated factors of cardiovascular disease. 
Meanwhile, comparison of individuals with and without high 
TG/HDL-C and LDL-C/HDL-C ratios over the follow-up 
period can be of help in the demonstration of their predictive 
abilities. 
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